Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
3,597,093
-
Shares change
-
+1,455,671
-
Total reported value, excl. options
-
$59,310,105
-
Value change
-
+$24,181,685
-
Put/Call ratio
-
1.89%
-
Number of buys
-
25
-
Number of sells
-
-19
-
Price
-
$16.48
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2017
61 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2017.
XBiotech Inc. - Common Shares, no par value (XBIT) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,597,093 shares
of 33,289,095 outstanding shares and own 10.81% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,291,158 shares), VANGUARD GROUP INC (744,176 shares), STATE STREET CORP (286,335 shares), NORTHERN TRUST CORP (229,979 shares), GEODE CAPITAL MANAGEMENT, LLC (152,318 shares), GOLDMAN SACHS GROUP INC (98,799 shares), Bank of New York Mellon Corp (71,568 shares), BALYASNY ASSET MANAGEMENT LLC (65,000 shares), SCHWAB CHARLES INVESTMENT MANAGEMENT INC (64,203 shares), and Capital Impact Advisors, LLC (52,289 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.